BBNX
Beta Bionics, Inc.
Key Financials
Revenue
$100.3M
↑ 53.9%
Gross Profit
$55.5M
↑ 54.8%
Operating Income
$-71681000
↓ 58.4%
Net Income
$-73200000
↓ 33.7%
EPS (Diluted)
$-1.81
↑ 79.0%
Total Liabilities
$41.1M
↓ 44.1%
Shareholders' Equity
$287.6M
↑ 217.2%
Cash & Equivalents
$31.6M
↑ 3.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/13/2026 | View on SEC |
| 10-Q | 7/29/2026 | View on SEC |
| 8-K | 7/29/2026 | View on SEC |
| SCHEDULE 13G | 7/24/2026 | View on SEC |
| 4/A | 7/2/2026 | View on SEC |
| 4 | 6/30/2026 | View on SEC |
| 144 | 6/29/2026 | View on SEC |
| 144 | 6/26/2026 | View on SEC |
| 4 | 6/25/2026 | View on SEC |
| 4 | 6/25/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BBNX |
| Company Name | Beta Bionics, Inc. |
| CIK | 1674632 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 949-427-7785 |